A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...
Parts Cleaner and Degreaser is put to the test in this video featuring @CRCAutoUS. Discover its performance and effectiveness ...
Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...
Special Report: Rhythm Biosciences surged more than 30% on Friday after confirming the commercial launch of its ColoSTAT blood test in Australia, enabled by its renewed ISO accreditation. Rhythm ...
A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks. The service ...
Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...